1,175 Shares in Chemed Corporation $CHE Acquired by Capstone Investment Advisors LLC

Capstone Investment Advisors LLC purchased a new position in Chemed Corporation (NYSE:CHE) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,175 shares of the company’s stock, valued at approximately $547,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geneos Wealth Management Inc. lifted its stake in shares of Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after purchasing an additional 4,560 shares during the period. Marshall Wace LLP purchased a new stake in Chemed in the second quarter worth $579,000. Brown Advisory Inc. grew its stake in Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after purchasing an additional 148 shares during the period. Finally, Cerity Partners LLC raised its holdings in Chemed by 237.7% in the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after purchasing an additional 3,133 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on CHE. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Oppenheimer boosted their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Finally, Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Chemed has an average rating of “Hold” and a consensus price target of $530.75.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director owned 3,533 shares in the company, valued at $1,879,556. This represents a 5.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 6,537 shares of company stock valued at $3,406,014 over the last quarter. 3.33% of the stock is owned by insiders.

Chemed Stock Performance

Shares of CHE opened at $523.57 on Friday. The business has a fifty day moving average of $509.45 and a 200 day moving average of $449.67. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The firm has a market capitalization of $6.84 billion, a P/E ratio of 26.30, a PEG ratio of 1.97 and a beta of 0.51.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same quarter in the previous year, the company posted $4.27 earnings per share. Chemed’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is currently 14.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.